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Human cognitive and social-emotional behaviors are heterogeneous, underscoring the challenges in
modeling pathogenesis in disorders of neurodevelopmental origin in which these domains are dysfunctional.
In general, animal models for these disorders are built to emulate our understanding of the clinical diagnosis,
with mixed results. We suggest the utility of model systems lies in the use of different strategies to perturb
hierarchical circuit development, to examine the behavioral dimensions that are most impacted, and to
discern the capacity for, and heterogeneity of, neuroadaptation that will then inform treatment strategies.Introduction
The traditional role of basic scientific discoveries in under-
standing childhood and adult-onset disorders of neurodevelop-
mental origin is generating testable hypotheses regarding the
etiology (genetic, environmental, and interactions between the
two) and determining how underlying neurobiological mecha-
nisms generate a particular disorder. The ultimate goal of inter-
facing basic and clinical research findings, therefore, is to
generate new strategies for treatment options (e.g., behavioral,
pharmaceutical, combination of both), which is currently under-
represented. Although the cognitive and psychiatric disorders
under discussion are uniquely human (and we note that not all
psychiatric disorders have been shown to have a neurodevelop-
mental basis), clinical research of what we will refer to collec-
tively as neurodevelopmental disorders is limited in its capacity
for determining etiology, and in understanding the biological
consequences of the disorder on the brain (limited mostly to
descriptive genetics, imaging, and postmortem studies). There
are recent, high-quality reviews on the topic of animal models
of specific, developmentally based cognitive and psychiatric
disorders (Ehninger et al., 2008; Fisch, 2007; Flint and Shifman,
2008; Insel, 2007; Kellendonk et al., 2009) and many more
peer-review studies. The sheer number and rapidity of appear-
ance of new findings in models is staggering. Here, we have
elected not to provide a traditional review. Rather, we inventory
fundamental strengths and weaknesses of specific strategies
and emphasize the gains to be made in understanding disorder
pathogenesis by addressing the developmental nature of early
and adult-onset dysfunction. Experimental strategies targeting
the clinical-basic interface provide opportunities to probe
deeper into the hierarchical and integrative nature of circuit
development, the impact that developmental disturbances
have on these processes, and the adaptive capacity to manage
the influences of gene and environmental insults.
Howdowemake the fundamental connections through animal
research? First, it is worthwhile noting that while continuing to be702 Neuron 67, September 9, 2010 ª2010 Elsevier Inc.long on clinical descriptions, recently, a more fundamental
understanding of neurodevelopmental disorders has occurred
in part through the rapid introduction of genetic models that
parallel discoveries in human genetics of specific syndromic
mutations and copy number or idiopathic genetic variations
(Chen et al., 2001; Nakatani et al., 2009). Yet, the strategies
have been mechanistically limited, and there is instead a dearth
of studies focusing on developmental time periods. These time
periods represent either disorder onset or, for certain adult
psychiatric disorders, such as schizophrenia, an altered devel-
opmental trajectory (Lewis and Levitt, 2002; Paus et al., 2008)
and the accompanying acute and long-term allostatic load
(McEwen and Wingfield, 2003) that leads to psychopathology
(Thompson and Levitt, 2010). This concept of importance of
development extends beyond the classic diathesis-stress model
of mental illness focusing on adult life events that interact with
heritable risk (Holmes and Rahe, 1967; Lieberman et al., 2001).
Yet, even without mechanistic data, we recognize the existence
of developmental phenomena that establish early vulnerabilities.
For example, population studies in humans illustrate the influ-
ence of early toxic stress (in the form of abuse, neglect, exposure
to toxins and drugs of abuse, maternal depression) in creating
a lifetime of increased risk for developing both psychiatric and
systemic (e.g., cancer, cardiovascular) disorders (Edwards
et al., 2003; Felitti et al., 1998) and genetic mediators of risk titra-
tion (Caspi et al., 2002, 2003). In animals, genetic models have
illustrated a similar biological phenomena, in which early disrup-
tion of particular genes, such as 5HT1aR (Gross et al., 2002),
DISC1 (Hikida et al., 2007; Niwa et al., 2010) and TGF-a (Koshibu
and Levitt, 2008), results in late adolescence or adult-onset
dysfunction. From this perspective therefore, we emphasize
that whether model systems are designed to study the early
onset of dysfunction, the culmination of developmental pertur-
bation postadolescence, or adult contributions to pathophysi-
ology, clinical advances will come from defining mechanisms
that tie timing of disruption to poor circuit adaptation, the impact
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or complex functional problems.
Even for defined syndromic neurodevelopmental disorders,
with known biomarkers, introducing a causal mutation and the
resulting pathophysiology within neurobiological substrates
can be highly varied (see below). Perhaps this should not be
surprising, given the clinical heterogeneity of disorders defined
by single-gene mutations. However, one view of the strength
of model systems is the ability to provide phenotypic consis-
tency and reproducibility while deciphering biological mecha-
nisms. Yet there remain practical pressures of defining more
biomarkers, particularly for disorders in which such features
currently are lacking (psychosis, autism), and testing their validity
as disorder-causing in model systems. How, then, can advances
in pathogenesis be made via the clinical-basic interface? We
suggest that addressing how risk factors, both genetic and envi-
ronmental, modify the fundamental, evolutionary conserved
process of hierarchical circuit and skill development is ripe for
discovery. This also has the possibility of leading to the identifi-
cation of subclinical, intermediate endophenotypes which, when
translated into clinical populations, may be useful in assessing
developmental trajectory and intervention outcomes, either
as treatments that redirect development or as preventive
measures. For example, in early ASD interventions, targeted
environmental enrichment is used to positively influence socially
relevant sensory information processing that is critical for later-
developing social cognition (Vismara and Rogers, 2010).
Neurodevelopment Hierarchies as a Focus
for Understanding Disorder Pathogenesis
Neurodevelopmental disorders are often systemic in nature—
that is, peripheral organ disruptions, dysmorphologies, and
primary sensory and motor dysfunctions are common in both
syndromic and idiopathic disorders (Carvill, 2001;Cooper-Brown
et al., 2008; Geschwind, 2009). Despite this, however, the cere-
bral cortex and associated forebrain circuits have been the foci
of intense developmental and clinical investigations. This focus
is expected, given the complexity of the cognitive and social-
emotional regulatory disturbances that characterize neurodeve-
lopmental disorders, the utilization of pathophysiologic pheno-
types in these functional domains as diagnostic features for
each disorder, and the well-documented role of neocortical
circuitry in higher-order information processing. The develop-
mental events in humans, monkeys, and model vertebrates that
define the assembly of a subset of dorsal pallial structures,
including neo- and association cortices and hippocampus, are
extraordinarily well-detailed across species (Rakic, 2009). We
know when and where neurogenesis, cell migration, tract forma-
tion, and neuronal specialization occur. We have a reasonable
view of synaptogenesis, though not in nearly the same detail.
Furthermore, we know that at some point in time during develop-
ment, genes that comprise nearly the entire genome are
expressed in the brain (Ramsko¨ld et al., 2009), and many of the
gene products are functionally pleiotropic. This reflects a combi-
natorial molecular system that is farmore complex than the linear
strategies used for perturbation of one gene at a time in animal
models. Candidate gene products that are involved in individual
histogenic events are plentiful (literally in the thousands), andwe know much about their expression patterns in rodents.
Knowledge in gyrencephalic animals lags significantly, but new
mapping and next-generation sequencing methods will provide
even more insight into the unique molecular properties of the
primate brain. However, even with this additional knowledge,
the gaps in mechanistic insight remain significant, and we
suggest serve as the primary source of challenges in gaining
pathogenic insight of neurodevelopmental disorders.
With a diversity of anatomical and molecular targets on which
to focus, it makes sense to highlight the principle information-
processing unit, the cortical minicolumn (Mountcastle, 1997),
which is both highly conserved in vertebrate evolution, and likely
to be a primary or secondary target of disruption based on
limited neuropathological studies in a variety of neurodevelop-
mental disorders (Casanova et al., 2003, 2008; Courchesne
and Pierce, 2005). The importance of deciphering these mecha-
nisms is highlighted by the recent discovery that Eph-ephrin-A
signaling mediates the dispersion of clonally related neurons
destined for neocortical columns (Torii et al., 2009). This recent
finding is consistent with specific EphA receptors as risk genes
for psychosis (Purcell et al., 2009). It also is an example of a
clinical-basic interface that could postulate that in schizo-
phrenia, there is an early disruption of the organization of the
key cortical information-processing unit. Expression patterns
of EphAs during primate corticogenesis (Donoghue and Rakic,
1999) can help determine the temporal and spatial vulnerability
of specific circuits that, if disrupted during development, can
result in psychiatric disorders.
The example referenced above reflects a strategy of address-
ing core pathogenic mechanisms of neurodevelopmentally
based disorders through investigation of the developmental
assembly and integrity of both architectural and ultimately
functional hierarchies. This approach acknowledges a funda-
mental property of the nervous system—that basic circuitry
components that underlie the organism’s ability to utilize sensory
information from its environment to respond appropriately and
maintain homeostatic balance are built first, followed by an inte-
gration of this basic information into complex circuit hierarchies
that process demanding information (Hammock and Levitt,
2006). In fact, this view is supported more by functional studies
rather than neurodevelopmental analyses of complex circuitry.
Simply stated, we know little about the development of circuit
hierarchies from neuroanatomical and molecular perspectives.
Instead, data are much more robust regarding functional, funda-
mental sensory and motor development across vertebrates, and
emotional and cognitive development in humans. The hierar-
chical nature of the emergence of primary sensory modalities,
language, and then top-down frontal cortical control (executive
function) in humans is well reviewed (Fox et al., 2010). In the
structural and molecular domains, however, there are few
studies that have examined directly the development of key
circuitry involved in higher-order information processing. For
example knowledge regarding the ontogeny of cortico-thalamic
(Auladell et al., 2000; Torii and Levitt, 2005), and cortico-striatal
connectivity (Sharpe and Tepper, 1998) (not simply axon pene-
tration into targets) is minimal, despite existing techniques that
could probe these connections. Yet the cortex provides the
vast majority of the synapses to these subcortical structuresNeuron 67, September 9, 2010 ª2010 Elsevier Inc. 703
Figure 1. Animal Model Examination of
Neural Circuit and Functional Hierarchies
Related to Disorder Pathogenesis
Here, we use an example from the development of
skill sets for complex social-emotional regulation.
Fundamental abilities are assembled in a hierar-
chical fashion throughout, which is comprised of
basic functions building upon each other to
develop the complex skill set. The underlying
neurobiological circuits underlying these indi-
vidual skill sets are shown, also developing in
hierarchical fashion, with the more complex, top-
down regulatory circuits forming late in develop-
ment. Rather than measuring end-state, complex
functions, dissecting components during
assembly in development will provide key insights
regarding pathogenesis. For example, genetic and
environmental challenges to the organism can
lead to widespread disruptions (A), intermediate
disruptions (B), or disruptions confined to partic-
ular, late-developing skill sets (C), depending on
the maturational stage of the neural circuitry
when the perturbation occurs. (D) For adult-onset
disorders with a neurodevelopmental basis, chal-
lenges acutely may not impact function overtly,
but over time, for example through allostatic
overload (see Figure 2), perturbations may
emerge. In each of these examples, intermediate
developmental pathophysiological states can be
examined in animal models in far more detail,
yielding information useful for intervention or
prevention designs.
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onset of synapse formation within the central circuitry that is
involved in integrating autonomic and hypothalamo-pituitary-
adrenal (HPA) functions, we showed that brainstem to peripheral
structure connectivity and hypothalamus to brainstem connec-
tivity are assembled in the rodent by birth (Rinaman et al.,
2000). While the descending axonal input to brainstem targets
from the amygdala and frontal cortex are present during the first
few days after birth, the onset of synaptogenesis is delayed by
almost one week (Rinaman et al., 2000). This coincides with
the period of time when maternal influences on pup physiology
and behavior aremost profound (Moriceau et al., 2006; Shionoya
et al., 2007). In fact, introduction of stressors can change the
timing of onset of synapse formation in the higher-order, later-
developing circuits while having no impact on the basic hypo-
thalamo-brainstem connections (Banihashemi and Rinaman,
2010; Card et al., 2005). Molecular physiology methods can be
adapted for examining developmental trajectory of circuitry.
For example, lentivirus-transduced channelrhodopsin could be
used to selectively activate anatomically defined circuits. This
would allow monitoring of postsynaptic responsiveness and
perhaps even adaptations following particular interventions in
animal models (Cruikshank et al., 2010). The improved resolution
of methods used for live imaging provides opportunities to
examine circuit function and plasticity over developmental
epochs (Cruz-Martı´n et al., 2010; Trachtenberg et al., 2002).
These approaches reveal the importance of timing in terms of704 Neuron 67, September 9, 2010 ª2010 Elsevier Inc.disrupting the hierarchical nature of circuit development and
the analysis of the basic elements that comprise more complex
behavioral dimensions such as social cognition and executive
function (Hammock and Levitt, 2006). Early alterations to the
circuitry underlying a specific functional modality can lead to
more widespread disruptions (e.g., autonomic nervous system
disruption and systemic dysautonomia [Axelrod et al., 2002]),
whereas later perturbations may lead to more specific disrup-
tions within a particular skill set but may not necessarily have
a broad impact (e.g., postnatal toxic stressors and emotional
dysregulation [Caspi et al., 2003; Plotsky and Meaney, 1993]).
Thus, the same insult, but presented at different times during
development, is likely to lead to very different outcomes (Figure 1)
based on the relative degree of maturation of neural circuits (i.e.,
the breadth of connections) and the particular role played by
a molecular component present during development compared
to the adult. In fact, in animal studies examining structure-
function effects of prenatal cocaine exposure, timing of expo-
sure was one of several key variables in explaining variance
across models (Stanwood and Levitt, 2008). Similarly, deletion
of 5HT1aR only during development results in very distinct
adult-onset emotion regulation outcomes compared to deletion
of the gene encoding the receptor in the adult mouse (Gross
et al., 2002). How this temporally circumscribed manipulation
results in long-term changes remains unknown. One hypothesis
is that this receptor modulates the assembly of relevant circuits
during development and then switches its role as a traditional
Figure 2. Adult-Onset and Developmentally Expressed Disorders
Involve Distinct Adaptive Responses to Genetic and Environmental
Challenges
Here, we illustrate homeostasis and neural adaptation in response to chal-
lenging stimuli (adapted from Koob and Le Moal, 2001). An organism must
continuously respond to both external and internal stimuli, maintaining an
equilibrated balance (solid red line in A), in which there are peak and trough
responses to stimuli (dotted red lines in A). In neurotypical individuals, these
responses average out into a constant homeostatic set point. If the system
is challenged by either a single, potent stimuli or through repeated,
subthreshold stimuli, the system may not have the time or capacity to equili-
brate to homeostasis (allostatic load). Instead, a weakened peak response
to stimuli is generated, which is matched in intensity by the same opponent
response (dotted green line in B). As the system attempts to create homeo-
stasis between these two responses, a new homeostatic set-point is achieved
(solid green line in B). Extreme challenges to homeostasis (perhaps a combina-
tion of genetic load interacting with potent environmental stimulus) can
produce allostatic overload, resulting in allostasis existing outside the
typical boundaries for homeostasis (purple lines in C). This overload may
have a profound impact on developmental trajectories and expression of
pathophysiologic functions.
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rupting this receptor during development could directly alter
neural circuitry. There is precedence for 5-HT serving this novel
developmental role (Bonnin et al., 2007), but relevant studies
examining the ontogeny of amygdala and related circuits in the
5HT1aR conditional null mouse should assess this directly.
Developmental Perturbation andNeural (Mal)Adaptation
as a Disorder Target
Adaptive capacities are well-described in stable, adult states
that define homeostatic balance. Homeostasis is not a new
concept, defining how external stimuli act upon neural systems
in a dynamic way. Whereas a potent single event has the poten-
tial to disrupt the development of hierarchical skills, weak
repeated stimuli also can lead to permanent changes to the
system. Neural circuits are fine-tuned by experience to be
resilient to a wide range of external stimuli. These circuits
demonstrate adaptive capacity through homeostatic regulation
(Knudsen et al., 2006). This classic concept includes physiolog-
ical understanding of neuroadaptation. Moreover, the mecha-
nisms underlying adaptive responses are significantly advanced
and complex. Homeostatic adaptation is responsible for driving
multiple cellular (e.g., pH and ATP stability) and whole-animal
behaviors (e.g., food foraging). Behavioral homeostasis regu-
lates both survival and nonessential behaviors and is the basis
for adaptive processes as wide-ranging as color vision (Hurvich
and Jameson, 1957), hedonism (Solomon and Corbit, 1974), and
drug addiction (Koob and Le Moal, 2001). Repeated challenges
to a system in homeostatic balance can result in system break-
down. This chronic challenge to homeostasis results in allostatic
states, culminating in allostatic load that leads to permanent
changes in homeostasis (McEwen, 2000; McEwen and Wing-
field, 2003). In fact, new allostasis may exist outside the typical
boundaries for homeostasis (allostatic overload) (Figure 2).
The developmental impact of allostatic load, however, is
underinvestigated and may be quite different from what is
reported in the adult (Lupien et al., 2009; McEwen, 2001).
Chronic high levels of glucocorticoids in the adult rodent or
nonhuman primate can permanently damage prefrontal cortical
and hippocampal neurons (Radley et al., 2004; Sapolsky et al.,
1985; Uno et al., 1989). During development, this same challenge
may also alter the fundamental wiring of circuits that mediate the
stress response (Plotsky and Meaney, 1993; Wei et al., 2007).
Thus, in the context of adult-onset disorders that originate in
development, allostatic overload may result in an altered
developmental trajectory (Thompson and Levitt, 2010). This
changed trajectory alone, or in combination with other environ-
mental challenges, could possibly lead to a diseased/disordered
system, for example schizophrenia. As such, behavioral and
etiological heterogeneity within each disorder is easier to under-
stand, as disorder onset would require multiple events (environ-
mental, genetic, interactions) to occur, and does not necessitate
identical causality, nor the identical trajectory of biological devel-
opment even within a single clinical population. Mechanistically,
this has emerged through the long-held concept of ‘‘early life
programming,’’ with the growth of epigenetic studies examining
the permanent and transient nature of genomic modifications
(Bale et al., 2010; Weaver et al., 2004). The concept of earlyallostatic overload is not without precedence. For example, allo-
static overload is likely to occur in premature onset of adult
hypertension, where reduction in the number of kidney glomeruli,
established prenatally, is accompanied by a maladaptive patho-
logical increase in glomerular size, correlating with disease
vulnerability (Keller et al., 2003). Rather than focusing on end
state, examining developmental changes following genetic
and/or environmental perturbations in animal models will provide
information regarding themaladaptive nature of the fundamental
molecular and structural architecture in the brain that underlies
a particular disorder pathophysiology, especially for childhood-
onset disorders. This also provides opportunities to examine
normal system interactions as skills are built, thus introducing
more naturalistic, integrated strategies.
The Heterogeneity of Neurodevelopmental Disorders
The collection of symptoms, subjectively reported and observed
(positive and negative symptoms in the case of schizophrenia, or
the triad of symptoms for ASD) defines a single disorder cate-
gory, in accordance with the existing diagnostic manuals. The
well-documented clinical heterogeneity that characterizes even
single-gene, syndromic disorders such as Rett (Chahrour and
Zoghbi, 2007; Dragich et al., 2000) or fragile X (Loesch et al.,Neuron 67, September 9, 2010 ª2010 Elsevier Inc. 705
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neity of overlapping but not identical pathophysiology. This is
an important consideration not only for the design of future
diagnostic tools but also for current and future strategies of
modeling the biological bases of neurodevelopmental disorders.
The concept of using a more discrete approach in studying
psychiatric disorders is gaining momentum for both the neuro-
science and clinical psychology research fields (Bale et al.,
2010; Insel, 2007, 2009). Though there are debates regarding
the advantages of studying discrete or dimensional behavioral
states (Mendl et al., 2010), here we emphasize that methods
should be developed focusing on the development of struc-
ture-function relations between component parts comprising
cognitive and social-emotional skills, specifically, those that
are often disrupted in neurodevelopmental disorders. Ultimately,
this will be more productive than debating the validity of whether
a model truly replicates a clinical state. A complexity to this, of
course, is that individual disrupted dimensions are often shared
across multiple disorders. For example, prepulse inhibition,
a type of sensorimotor gating, is deficient in both autism and
schizophrenia (Braff et al., 1978; Grillon et al., 1992; Perry
et al., 2007). Additionally, generalized anxiety disorder appears
in a number of neurodevelopmental disorders of distinct genetic
etiology, including Williams syndrome, ASD, and schizophrenia
(Davis et al., 2008; Dykens, 2003; Tibbo et al., 2003). Although
mostly studied in the adult genetically manipulated animal
models for each disorder, the developmental trajectory of senso-
rimotor gating or emotional regulation may provide more insight
regarding hierarchical events that may be differentially disrupted
in disorders. For example, these hierarchical events may be
acutely disrupted in autism, yet more chronically, though
perhaps initially more subtly, disrupted in schizophrenia.
Adding to the complexity of disorder heterogeneity based on
clinical observation is clear evidence for multiple genetic mech-
anisms (Geschwind, 2009) contributing to idiopathic disorders
such as ASD (Abrahams and Geschwind, 2010) and schizo-
phrenia (Owen et al., 2010). Both very small or modest contribu-
tors to disorders, like common polymorphisms (Campbell et al.,
2006; Anney et al., 2010; Stefansson et al., 2009; Wang et al.,
2009), and potentially major contributors, such as rare coding
mutations and copy number variations (Christian et al., 2008;
Glessner et al., 2009; Merikangas et al., 2009; Sebat et al.,
2007; Weiss et al., 2008), are themselves heterogeneous in
disorder impact. Common risk alleles are, by themselves, only
moderators of physiological states. Moreover, there are now
several descriptions in which well-defined mutations present in
neurotypical individuals within a family that also include an
affected person with the mutation (Sebat et al., 2007). Emerging
from these genetic studies is a perspective emphasizing the
importance of defining the molecular and neurobiological path-
ways that are disrupted (Akil et al., 2010; Bill and Geschwind,
2009; El-Fishawy and State, 2010; Levitt and Campbell, 2009).
This parallels an initial conceptualization, put forth in previous
gene microarray studies (Mirnics et al., 2000, 2001), of targeting
defined molecular networks that are specific to a particular
disorder, though achievable through different genetic and envi-
ronmental mechanisms across subjects, that therefore intro-
duces clinical heterogeneity.706 Neuron 67, September 9, 2010 ª2010 Elsevier Inc.TheClinical-Basic Interface in Designing AnimalModels
How does the field cope with and characterize the phenotypic
and etiological heterogeneities that are recognized as underlying
neurodevelopmental disorders? Additional challenges include
the complexity of relating models to diagnostic criteria (e.g., in
DSM, ICD, or other instruments) that may include clinical symp-
toms only, or in addition, etiological information, such as neuro-
pathological markers. Animal models, however, are controllable
and thus provide unique experimental substrates for investi-
gating neurobiological mechanisms and consequences of
neurodevelopmental disorders beyond what is possible in
clinical populations. Furthermore, animal models need notmimic
the human disorder, not just because it cannot, but because it
need not to be useful. For example, Rett syndrome afflicts girls
almost exclusively. Yet introduction of a mutation in the gene
encoding MeCP2, the gene that causes the disorder, into mice
generates severe functional phenotypes in male mice (Chen
et al., 2001; Guy et al., 2001; Shahbazian et al., 2002). A search
for the presumed genetic modifiers or unique aspects of mosa-
icism in humans and mice will be useful. The animal model itself,
which does not mimic a fundamental aspect of the clinical
disorder (sex bias), nonetheless has allowed for a greater under-
standing of MeCP2 in neurodevelopmental processes and in
designing and implementing preclinical pharmacological treat-
ments for reversing the resultant phenotypes (Guy et al., 2007;
Tropea et al., 2009). Another example is that of a rare mutation
in neuroligin 3. The coding variant, introduced in one mouse
line, produced interesting cognitive phenotypes (Tabuchi et al.,
2007) that were not replicated when the identical mutation was
used by another laboratory to create an independent mouse
line using a congenic rather than hybrid mouse strain (Chadman
et al., 2008). It may be that these genetic models are more useful
for dissecting the presence or absence of adaptive capacities of
specific developing synapses or identifying genetic background
modifiers or environmental factors (that may differ between
laboratories) as phenotype modifiers, rather than promoting
them as clinical models, per se.
Modeling a biological process that is disrupted in the disorder,
rather than producing ‘‘the’’ clinical model is achievable. Nine
factors, not exhaustive in nature, are presented here as consid-
erations for the design and utilization of experimental animal
models of neurodevelopmental disorders (Figure 3). This is pre-
sented in the spirit of moving away from the need to design
models that mimic the diagnostic criteria of an early- or late-
onset disorder, to instead, approaches that may provide more
relevant experimental data and thus inform better intervention
designs. Moreover, this allows for individual behaviors to be
studied, which when disrupted, are often shared across multiple
neurodevelopmental disorders. Understanding the develop-
mental disruptions that lead to aberrant behavior provides
insight into common circuit problems and possible treatment
strategies that can be shared across these disorders. The nine
considerations follow.
(1) Ethologically Appropriate Behavior
Insight can be gained either from probing functions that are
conserved across species boundaries (e.g., sensorimotor
gating; Powell et al., 2009) or common functions that are ex-
pressed in distinct, species-relevant ways. Regarding the latter,
Figure 3. A Short List of Considerations
Informing the Design of Relevant Animal
Models to Study the Etiology and
Pathophysiology of Neurodevelopmental
Disorders
Some elements, like ethologically relevant behav-
iors, species-specific timing of histogenic events,
and species-unique environmental impact, are
noteworthy for their influence on model design.
Others are typically not considered, like differ-
ences in regulation and patterns of gene expres-
sion, and neural and nonneural system interactions
in a species-relevant manner. These components
provide opportunities to examine disorder-rele-
vant processes from the perspective of neurobio-
logical and behavioral hierarchies.
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sensory modalities, or unique predator-prey relationships are
features that can be used to an advantage in designing models.
The stressors introduced by intermittent removal of offspring
from the dam reflect careful design of an environmental factor
that takes advantage of species-unique characteristics (Men-
doza et al., 1978; Plotsky and Meaney, 1993; Suchecki et al.,
1993). These studies in turn have led to common themes of
epigenetic modulation of the impact of early stress on brain
development and function in animal models (Weaver et al.,
2004) and humans (McGowan et al., 2009).
(2) The Presence of Species-Specific Genetic Modifiers
The emergence of more detailed information regarding genetic
modulatory factors will lead to better model design to probe
similarities and differences between a clinical dimension of
a disorder and phenotypes in models using the same mutations.
For example, the rare coding mutation in the human serotonin
transporter (SERT) associated with ASD and comorbid with
obsessive-compulsive behavior is an intrinsic variant to the
C57BL6J mouse (Carneiro et al., 2009), which may impact
specific behavioral traits of the wild-type mouse. However, while
this strain is used in the majority of gene-targeting studies, and
the presence of the SERT variant could impact phenotypes,
the wild-type strain is not used as a model of either ASD or OCD.
(3) Species-Specific Timing of Histogenic Events
Cortical synaptogenesis, for example, begins in earnest during
the third trimester in primate species, but postnatally in rodents
(Thompson et al., 2009). This detail impacts the design of
environmental manipulations for perturbing this developmental
process.Neuron 67, S(4) Species-Dependent Regulation
and Patterning of Gene Expression
Information on transcriptional regulation
of risk genes, detailed spatiotemporal
developmental expression patterns,
and their genetic modifiers provide a
foundation for relating genetic manipula-
tions in animal models to human. How-
ever, the limited data to date poses pro-
blems for designing appropriate studies.
Constitutive or conditional introduction
of gene mutations, disorder-specificrare variants, manipulation of expression via RNAi or shRNA
transfer, or viral expression vectors all promote the examina-
tion of genetic mechanisms that may underlie a pathophysio-
logical state. Each technique has strengths and weaknesses,
and none, even those that introduce a clinically defined muta-
tion, need to phenocopy the disorder to make valuable con-
tributions to understanding neurodevelopmental pathogenic
processes.
(5) Species-Specific Representation of Circuits
and Their Individual Components
The debate regarding the presence or absence of prefrontal
cortex in rodents notwithstanding, consideration of structure-
function relations from a developmental perspective enhances
animal model studies. Recent history however reflects oversight
of this consideration, for genes are introduced, behaviors mea-
sured, and drugs given to reverse one or two elements of a
phenotype. Studies of neurodevelopmental disorders incorpo-
rating relationships between neuroanatomical substrates may
providemore comprehensive intervention strategies, specifically
targeting these circuits and substrates using pharmacological
and experience-based approaches.
(6) Species-Relevant Environmental Impact
Similar to selecting ethologically appropriate behavioral tasks,
putative environmental factors that impact developing systems
should also be considered.
(7) Species-Unique Metabolic and Homeostatic Systems
Allostatic load and developmental homeostatic challenges are
impacted by species-unique mechanisms responsible for
controlling metabolic and physiologic states. This also can be
used to an advantage in designing animal model studies.eptember 9, 2010 ª2010 Elsevier Inc. 707
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Interactions
Animal models could be designed to explore these relationships,
which may be useful for understanding pathogenesis and
treatment approaches. For example, there is substantial
co-occurrence of seizures inmultiple neurodevelopmental disor-
ders (Gaitatzis et al., 2004; Matsuo et al., 2010), though this
particular pathophysiology may not be represented or focused
upon in model systems designed to mirror the clinical disorder.
Additionally, gastrointestinal disorders are prevalent among
individuals with ASD (Buie et al., 2010; Campbell et al., 2009),
but are not currently examined in animal models of ASD.
(9) Species-Specific Onset and Regulation of Puberty
This is specifically relevant for addressing sensitive and critical
periods of development that transition through puberty, which,
when perturbed can lead to adult-onset psychiatric disorders.
Mechanistically, experimental approaches in animal models
will assist in clarifying potential factors that influence postpuber-
tal pathophysiology emergence.
A Concluding Perspective on Animal Models
and Neurodevelopmental Disorders
The concept of probing early disruptions in development is
gaining momentum (Koshibu and Levitt, 2008; Moriceau et al.,
2006; Niwa et al., 2010; Shionoya et al., 2007). Partly responsible
for the limited number of studies to date is the lack of sufficiently
sophisticated behavioral and neuroanatomical probes relevant
for a young or developing animal. The field of animal models is
not alone in this challenge, as developmental psychologists
also must establish age-appropriate experimental designs that
probe typical development as well as clinical disorders. Not
surprisingly, similar to the development of complex circuits, the
emergence of complex behaviors also takes time. An early post-
natal mouse pup will devote a significant amount of time and
energy seekingwarmth and food frommom,whereas a prewean-
ling animal begins to explore and gain independence as they
forage for themselves. Therefore, a two-bottle choice test might
be an appropriate behavioral probe for sucrose preference and
motivation in a postweanling animal but will not provide insight
into the motivational systems of a young pup—despite intact
reward circuitry. Defining and utilizing species and develop-
mental stage-specific behaviors will facilitate the probing of
functional consequences of early disruptions of developing
circuits.
Emergence of disorder risk during development is a challenge
that the field will have to address more as we become more
adept at monitoring developmental trajectory. The relationship
between the dynamic structural changes of the cerebral cortex
in children and IQ measures, rather than end-state or cross-
sectional assays, illustrates the insight to be gained by moni-
toring intermediate states of development (Castellanos et al.,
2002; Shaw et al., 2006; Sowell et al., 2001). In an animal model,
experiments introducing a transient disruption of Disrupted in
Schizophrenia-1 (DISC 1) early in development (Niwa et al.,
2010) were able to dissociate early perturbations of neuronal
architecture and molecular systems from postpubertal onset of
altered cognitive and emotional behavior performance. While
the specific human translocation associated with schizophrenia708 Neuron 67, September 9, 2010 ª2010 Elsevier Inc.was not reproduced in mice, the study highlights a genetic
strategy for modeling intermediate phenotypes and a develop-
mental emergence of dysfunctional behavioral dimensions
relevant also in schizophrenia.
Striving to phenocopy neurodevelopmental disorders in
animal models or ignoring models that do not phenocopy disor-
ders diminishes the value of the resultant phenotypes that may
still lead to biological insight relevant to the disorder. For
example, the paternally inherited chromosome 15q11-13 dupli-
cation (Nakatani et al., 2009) in mice leads to important molec-
ular and behavioral changes that are similarly demonstrated in
ASD, yet the duplication in humans that results in ASD diagnosis
is maternally inherited. While not a genetic phenocopy, the
mouse model is nonetheless an important step for introducing
genetically engineered chromosomal loci and for assessing the
developmental impact that this type of duplication has on
emerging neural circuits. Additionally, maternally inherited dele-
tion of Ube3a, the gene holding the causal mutation for Angel-
man syndrome, generates a variety of interesting phenotypes,
including altered visual plasticity (Sato and Stryker, 2010; Ya-
shiro et al., 2009), learning and LTP deficits (Jiang et al., 1998;
Weeber et al., 2003), and even loss of midbrain dopamine
neurons (Mulherkar and Jana, 2010). In the mouse, however,
the reported imprinting of human gene expression within a very
limited number of structures does not occur (Gustin et al.,
2010). This reflects a challenge in mechanistic interpretations,
but thesemice remain of considerable interest for understanding
Ube3a function in the developing brain. Lack of expression of the
FMR1 gene causes fragile X syndrome, a highly heritable form of
mental retardation. Mice lacking this gene show significant
disruptions in cortical morphology and behavioral performance
similar to those demonstrated in fragile X syndrome, and the
reversal of some of these phenotypes by downstream interven-
tion strategies in adult mice (de Vrij et al., 2008; Do¨len et al., 2007;
Hayashi et al., 2007) has led to rapid development of clinical trials
(ClinicalTrials.gov, Clinical Trial Numbers NCT01015430 and
NCT00718341). Nonetheless, different mouse strains with the
identical, well-known FMR1 mutation can create experimental
havoc, producing opposite changes in the auditory acoustic
startle phenotype from one generation to the next. Perhaps
being problematic as a clinical phenocopy, the strain-specific
differences have led to the discovery of a limited number of
genetic loci that may serve as modifiers of the FMR1 mutation
in mice (Errijgers et al., 2008). This discovery also can be exam-
ined in humans for potential relevance to clinical heterogeneity in
fragile X syndrome.
Trying not to cast too broad a net, once identified as particular
risk or disorder-causing factors, we would argue that models
in which specific genetic or environmental manipulations are
introduced will be clinically relevant. The specificity and sensi-
tivity of a particularmodel relies on defining ethologically relevant
strategies for probing specific molecular and neural elements
that contribute to phenotype. For example, deciphering the
impact of a particular allelic variant in ASD on basic associative
learning skills integral to more complex social and emotional
regulation may provide novel insight that will lead to under-
standing the trajectory that a developing system may endure
as a result of the disorder. The resulting long-term challenges
Neuron
Perspectiveto the circuits and behavioral hierarchies, discovered through
animal model studies, can ultimately become targets of thera-
peutic strategies that engage the system at its most readily
responsive time for clinical treatment or even prevention.ACKNOWLEDGMENTS
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